Practice Guidelines for Cancer Pain Management.A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section.Anesthesiology, 84: 1243–57, 1996.
2.
CerfolioR.J., AllenM.S., TrastekV.F., DeschampsC., ScanlonP.D., PairoleroP.C.: Lung resection in patients with compromised pulmonary function.Ann Thorac Surg, 62: 348–351, 1996.
ZaricD., NydahlP.A., PhilipsonL., SamuelssonL., HeiersonA., AxelssonK.: The effect of continuous lumbar infusion of ropivacaine (0.1%, 0.2% and 0.3%) and 0.25% bupivacaine on sensory and motor block in volunteers: a double blind study.Reg Anesth, 21: 14–25, 1996.
5.
MuldoonT., MilliganK., QuinnP., ConnollyD.C., NilssonK.: Comparision between extradural infusion of ropivacaine or bupivacaine for the prevention of postoperative pain after total knee arthroplasty.Br J Anaesth, 80: 680–681, 1998.
6.
ReizS., HaggmarkS., JohanssonG., NathS.: Cardiotoxicity of ropivacaine a new amide local anesthetic agent.Acta Anaes-thesiol Scand, 33: 93–98, 1989.
7.
ScottD.A., EmanuelssonB.M., MooneyP.H., CookR.J., JunestrandC.: Pharmacokinetics and efficacy of long-term epidural ropivacaine infusion for postoperative analgesia.Anesth Analg, 85: 1322–1330, 1997.
8.
ScottB.: Acute toxicity of ropivacaine compared with that of bupivacaine.Anesth Analg, 69: 563–569, 1989.
SidebothamD.A.: Low dose fentanyl improves continuous bupivacaine epidural analgesia following orthopaedic, urological or general surgery.Acute Pain, 1: 27–32, 1997.
11.
de Leon-CasasolaO.A., LemaM.J.: Postoperative epidural opioid analgesia: what are the choices?Anesth Analg, 83: 867–875, 1996.
12.
HansdottirV., WoestenborghsR., NordbergG.: The pharmacokinetics of continuous epidural sufentanil and bupivacaine infusions after thoracotomy.Anesth Analg, 83: 394–406, 1996.
13.
TejwaniG.A., RattanA.K., McDonaldJ.S.: Role of spinal opioid receptors in the antinociceptive interactions between intrathecal morphine and bupivacaine.Anesth Analg, 84: 726–734, 1992.
